BIONEER CORPORATION
http://bioneer1.tradekorea.com
Bioneer is a leading supplier of synthetic DNA, providing high-quality custom oligos at affordable prices. Recent improvements in oligonucleotide synthesis chemistry has led to the production of higher quality oligonucleotides at lower cost. In addition, we have implemented in-house production of raw materials along with our proprietary DNA synthesis system, called 384 parallel super DNA synthesizer, and BioRP oligo purification technology (patent pending). Furthermore, we have recently completed a state-of-the-art oligo manufacturing facility capable of producing over 45,000 oligos /day. Such oligo production capacity enables us to meet above and beyond the needs of our customers.
Company Introduction
Bioneer is a leading supplier of synthetic DNA, providing high-quality custom oligos at affordable prices. Recent improvements in oligonucleotide synthesis chemistry has led to the production of higher quality oligonucleotides at lower cost.
In addition, we have implemented in-house production of raw materials along with our proprietary DNA synthesis system, called 384 parallel super DNA synthesizer, and BioRP oligo purification technology (patent pending).
Furthermore, we have recently completed a state-of-the-art oligo manufacturing facility capable of producing over 45,000 oligos /day. Such oligo production capacity enables us to meet above and beyond the needs of our customers.
Detailed Company Information
BIONEER CORPORATION
- Business Type
- Year Established
- Location South Korea
- Main Markets U. Kingdom,Israel,Iran,Japan,U.S.A
- Total Employees 101-500 People
- Homepage www.bioneer.com
- President PARK, HAN-OH
- Phone +82-42-930-8517 042-930-8517
- FAX +82-42-930-8688
- Address 49-3, Munpyeong-dong, Daedoek-gu, Daejeon
- Product Category Health & Medical > Health > Pharmaceuticals
- Factory Information
Additional Introduction
Bioneer is a leading supplier of synthetic DNA, providing high-quality custom oligos at affordable prices. Recent improvements in oligonucleotide synthesis chemistry has led to the production of higher quality oligonucleotides at lower cost.
In addition, we have implemented in-house production of raw materials along with our proprietary DNA synthesis system, called 384 parallel super DNA synthesizer, and BioRP oligo purification technology (patent pending).
Furthermore, we have recently completed a state-of-the-art oligo manufacturing facility capable of producing over 45,000 oligos /day. Such oligo production capacity enables us to meet above and beyond the needs of our customers.